Delivery Order SPE2DB20D2104-SPE2DB23FV55H
Award Date
9/27/23
Potential Completion Date
9/28/23
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,072.55 for the supply of Risperdal 1 mg tablets. The contract was awarded on April 21, 2022, by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support military...
This federal contract award, valued at $12,895.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Risperdal 4 mg tablets, a pharmaceutical product, with a completion date of May 16, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. The award was made without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,759.83 firm fixed-price delivery order contract is to supply Risperdal 1 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. While the original solicitation was not provided, the award indicates that it was not designated with any set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Risperdal 2 mg tablets. The award, valued at $1,536.79, is a firm fixed-price delivery order with an ultimate completion date of January 4, 2024. Amerisourcebergen is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Risperdal 2 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price, $10,348.17 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This federal contract award is for the delivery of Risperidone 1 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,789.14, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 7, 2022. The contract is a delivery order with a firm fixed price and has an ultimate completion date of October 11, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Risperidone 2 mg tablets. The $5,809.24 firm fixed-price contract has a completion date of November 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of RISPERDAL 0.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The $3,703.55 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 14, 2023. Amerisourcebergen is the prime contractor and does not have any listed subcontractors. The award is associated with a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Risperidone 2 mg tablets. The contract has a ceiling value of $5,546.16 and an ultimate completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $4,056.73, is for the delivery of the pharmaceutical product Risperdal 3 mg tablets. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive vehicle for the company to supply a range of pharmaceutical products and...